21 U.S.C. § 1710a — Requirement for disclosure of Federal

Page 990 TITLE 21—FOOD AND DRUGS § 1710a lated to drug interdiction, prior to repeal by Pub. L. 115–271, title VIII, § 8219(a), Oct. 24, 2018, 132 Stat. 4132. See 2018 and 2006 Amendment notes below. AMENDMENTS 2018—Pub. L. 115–271, § 8219(a), repealed Pub. L. 105–277, div. C, title VII, § 711, Oct. 21, 1998, 112 Stat. 2681–691. See 2006 Amendment note below. Pub. L. 115–271, § 8202(b)(2), repealed Pub. L. 105–277, § 715. See 1998 Amendment note below. Pub. L. 115–271, § 8202(a), revived and restored this sec- tion as in effect on Sept. 29, 2003, and as amended by Pub. L. 109–469 and Pub. L. 112–166. See Reauthorization of the Office of National Drug Control Policy note set out under section 1701 of this title. Subsec. (a)(1). Pub. L. 115–271, § 8219(b)(1)(A), sub- stituted ‘‘The Director shall designate or appoint an appointee in the Senior Executive Service or an ap- pointee in a position at level 15 of the General Schedule (or equivalent) as the United’’ for ‘‘The United’’ and ‘‘to perform’’ for ‘‘shall perform’’. Subsec. (a)(2)(B). Pub. L. 115–271, § 8219(b)(1)(B), sub- stituted ‘‘September 1’’ for ‘‘March 1’’ and ‘‘paragraph (4)’’ for ‘‘paragraph (3)’’. Subsec. (a)(3). Pub. L. 115–271, § 8219(b)(1)(C), struck out ‘‘also, at his discretion,’’ after ‘‘and may’’ and sub- stituted ‘‘assist in carrying out such responsibilities’’ for ‘‘the Office of Supply Reduction for that purpose’’. Subsec. (a)(4)(B). Pub. L. 115–271, § 8219(b)(1)(D)(i), sub- stituted ‘‘Before submission of the National Drug Con- trol Strategy or annual assessment required under sec- tion 1705 of this title, as applicable, the United’’ for ‘‘The United’’. Subsec. (a)(4)(C). Pub. L. 115–271, § 8219(b)(1)(D)(iv)(I), in introductory provisions, substituted ‘‘September 1’’ for ‘‘March 1’’ and ‘‘a report that’’ for ‘‘, which shall in- clude’’, inserted ‘‘the Director, acting through’’ after ‘‘each year,’’ and a comma after ‘‘Coordinator’’, and struck out ‘‘a report on behalf of the Director’’ after ‘‘shall provide’’. Pub. L. 115–271, § 8219(b)(1)(D)(ii), (iii), redesignated subpar. (D) as (C) and struck out former subpar. (C). Prior to amendment, text of subpar. (C) read as follows: ‘‘The National Interdiction Command and Control Plan shall not change existing agency authorities or the laws governing interagency relationships, but may in- clude recommendations about changes to such authori- ties or laws.’’ Subsec. (a)(4)(C)(i). Pub. L. 115–271, § 8219(b)(1)(D)(iv)(II), (III), inserted cl. (i) designation and introductory provisions and redesignated former cls. (i) to (iii) as subcls. (I) to (III), respectively, of cl. (i). Subsec. (a)(4)(C)(i)(I). Pub. L. 115–271, § 8219(b)(1)(D)(iv)(IV)(aa), inserted ‘‘, including informa- tion about how each National Drug Control Program agency conducting drug interdiction activities is en- gaging with relevant international partners’’ after ‘‘Plan’’. Subsec. (a)(4)(C)(i)(II). Pub. L. 115–271, § 8219(b)(1)(D)(iv)(IV)(bb), substituted ‘‘and statistical’’ for ‘‘, as well as statistical’’. Subsec. (a)(4)(C)(i)(III). Pub. L. 115–271, § 8219(b)(1)(D)(iv)(IV)(cc), substituted ‘‘and statistical’’ for ‘‘, as well as statistical’’ and ‘‘; and’’ for period at end. Subsec. (a)(4)(C)(ii). Pub. L. 115–271, § 8219(b)(1)(D)(iv)(V), added cl. (ii). Former cl. (ii) redes- ignated subcl. (II) of cl. (i). Subsec. (a)(4)(C)(iii). Pub. L. 115–271, § 8219(b)(1)(D)(iv)(II), redesignated cl. (iii) as subcl. (III) of cl. (i). Subsec. (a)(4)(D). Pub. L. 115–271, § 8219(b)(1)(D)(v), added subpar. (D). Subsec. (b)(1)(B). Pub. L. 115–271, § 8219(b)(2)(A), in- serted ‘‘and how to strengthen international partner- ships to better achieve the goals of that plan’’ after ‘‘that plan’’. Subsec. (b)(2). Pub. L. 115–271, § 8219(b)(2)(B), sub- stituted ‘‘Chairperson’’ for ‘‘Chairman’’ in heading and for ‘‘chairman’’ in text. Subsec. (b)(3). Pub. L. 115–271, § 8219(b)(2)(C), sub- stituted ‘‘before June 1’’ for ‘‘prior to March 1’’, ‘‘Chairperson’’ for ‘‘current chairman’’, and ‘‘the mem- bers may’’ for ‘‘they may’’ and struck out ‘‘either’’ after ‘‘the call of’’ and after ‘‘by the members’’. Subsec. (b)(4). Pub. L. 115–271, § 8219(b)(2)(D), struck out ‘‘a report’’ after ‘‘shall submit’’, inserted ‘‘a re- port’’ after ‘‘committees’’, and substituted ‘‘Chair- person of the Interdiction Committee’’ for ‘‘chairman of the Interdiction Committee’’ and ‘‘The report re- quired under this paragraph shall be in unclassified form, but may include a classified annex.’’ for ‘‘Any content of such a report that involves information clas- sified under criteria established by an Executive order, or whose public disclosure, as determined by the Direc- tor, the chairman, or any member, would be detri- mental to the law enforcement or national security ac- tivities of any Federal, State, local, or tribal agency, shall be presented to Congress separately from the rest of the report.’’ Subsec. (c). Pub. L. 115–271, § 8219(b)(3), added subsec. (c). 2006—Pub. L. 109–469, § 602, amended Pub. L. 105–277, § 715, which provided for the repeal of this section. See 1998 Amendment note below. Pub. L. 109–469, § 103(f)(1), directed that section 711 of Office of National Drug Control Policy Reauthorization Act of 1998 (Pub. L. 105–277, div. C, title VII) be amended by ‘‘adding at the end’’ a new section 711, which com- prises this section. A prior section 711 of the Act was repealed by Pub. L. 115–271, § 8219(a). See 2018 Amend- ment note above. 1998—Pub. L. 105–277, § 715, as amended by Pub. L. 109–469, § 602, which provided for the repeal of title VII of the Office of National Drug Control Policy Reauthor- ization Act of 1988 (Pub. L. 105–277, div. C, title VII) ef- fective Sept. 30, 2010, was repealed by Pub. L. 115–271, § 8202(b)(2). See former section 1712 of this title. § 1710a. Requirement for disclosure of Federal sponsorship of all Federal advertising or other communication materials (a) Requirement Each advertisement or other communication paid for by the Office, either directly or through a contract awarded by the Office, shall include a prominent notice informing the target audience that the advertisement or other communication is paid for by the Office. (b) Advertisement or other communication In this section, the term ‘‘advertisement or other communication’’ includes— (1) an advertisement disseminated in any form, including print or by any electronic means; and (2) a communication by an individual in any form, including speech, print, or by any elec- tronic means. (Pub. L. 105–277, div. C, title VII, § 712, as added Pub. L. 109–469, title XI, § 1118, Dec. 29, 2006, 120 Stat. 3546; amended Pub. L. 105–277, div. C. title VII, § 715, Oct. 21, 1998, 112 Stat. 2681–693; Pub. L. 109–469, title VI, § 602, Dec. 29, 2006, 120 Stat. 3533; Pub. L. 115–271, title VIII, § 8202(a), (b)(2), Oct. 24, 2018, 132 Stat. 4110.) Editorial Notes CODIFICATION Another section 712 of title VII of div. C of Pub. L. 105–277 amended former section 1509 of this title. AMENDMENTS 2018—Pub. L. 115–271, § 8202(b)(2), repealed Pub. L. 105–277, § 715. See 1998 Amendment note below. Page 991 TITLE 21—FOOD AND DRUGS § 1714 Pub. L. 115–271, § 8202(a), revived and restored this sec- tion as in effect on Sept. 29, 2003, and as amended by Pub. L. 109–469 and Pub. L. 112–166. See Reauthorization of the Office of National Drug Control Policy note set out under section 1701 of this title. 2006—Pub. L. 109–469, § 602, amended Pub. L. 105–277, § 715, which provided for the repeal of this section. See 1998 Amendment note below. 1998—Pub. L. 105–277, § 715, as amended by Pub. L. 109–469, § 602, which provided for the repeal of this sec- tion effective Sept. 30, 2010, was repealed by Pub. L. 115–271, § 8202(b)(2). See former section 1712 of this title. § 1711. Authorization of appropriations There are authorized to be appropriated to carry out this chapter except activities other- wise specified, to remain available until ex- pended, $18,400,000 for each of fiscal years 2018 through 2023. (Pub. L. 105–277, div. C, title VII, §§ 714, 715, Oct. 21, 1998, 112 Stat. 2681–693; Pub. L. 109–469, title VI, §§ 601, 602, Dec. 29, 2006, 120 Stat. 3533; Pub. L. 115–271, title VIII, § 8202, Oct. 24, 2018, 132 Stat. 4110.) Editorial Notes REFERENCES IN TEXT This chapter, referred to in text, was in the original ‘‘this title’’, meaning title VII of Pub. L. 105–277, div. C, Oct. 21, 1998, 112 Stat. 2681–670, which is classified prin- cipally to this chapter. For complete classification of title VII to the Code, see Short Title note set out under section 1701 of this title and Tables. AMENDMENTS 2018—Pub. L. 115–271, § 8202(b)(2), repealed Pub. L. 105–277, § 715. See 1998 Amendment note below. Pub. L. 115–271, § 8202(b)(1), substituted ‘‘$18,400,000 for each of fiscal years 2018 through 2023’’ for ‘‘such sums as may be necessary for each of fiscal years 2006 through 2010’’. Pub. L. 115–271, § 8202(a), revived and restored this sec- tion as in effect on Sept. 29, 2003, and as amended by Pub. L. 109–469 and Pub. L. 112–166. See Reauthorization of the Office of National Drug Control Policy note set out under section 1701 of this title. 2006—Pub. L. 109–469, § 602, amended Pub. L. 105–277, § 715, which provided for the repeal of this section. See 1998 Amendment note below. Pub. L. 109–469, § 601, substituted ‘‘chapter except ac- tivities otherwise specified,’’ for ‘‘chapter,’’ and ‘‘2006 through 2010’’ for ‘‘1999 through 2003’’. 1998—Pub. L. 105–277, § 715, as amended by Pub. L. 109–469, § 602, which provided for the repeal of this sec- tion effective Sept. 30, 2010, was repealed by Pub. L. 115–271, § 8202(b)(2). See former section 1712 of this title. Statutory Notes and Related Subsidiaries APPROPRIATIONS Provisions appropriating funds to carry out activities authorized by the Office of National Drug Control Pol- icy Reauthorization Act of 1998, which enacted this chapter, were contained in the following appropriation acts: Pub. L. 109–115, div. A, title V, Nov. 30, 2005, 119 Stat. 2475. Pub. L. 108–447, div. H, title III, Dec. 8, 2004, 118 Stat. 3249, 3250. Pub. L. 108–199, div. F, title III, Jan. 23, 2004, 118 Stat. 324. § 1712. Repealed. Pub. L. 115–271, title VIII, § 8202(b)(2), Oct. 24, 2018, 132 Stat. 4110 Section, Pub. L. 105–277, div. C, title VII, § 715, Oct. 21, 1998, 112 Stat. 2681–693; Pub. L. 109–469, title VI, § 602, Dec. 29, 2006, 120 Stat. 3533; Pub. L. 115–271, title VIII, § 8202(a), Oct. 24, 2018, 132 Stat. 4110, provided for the termination of Office of National Drug Control Policy and repealed this chapter effective Sept. 30, 2010. § 1713. Authorization of use of environmentally- approved herbicides to eliminate illicit nar- cotics crops The Secretary of State, the Attorney General, the Secretary of Agriculture, the Secretary of Defense, the Director of the Office of National Drug Control Policy, and the Administrator of the Environmental Protection Agency are au- thorized to support the development and use of environmentally-approved herbicides to elimi- nate illicit narcotics crops, including coca, can- nabis, and opium poppy, both in the United States and in foreign countries. (Pub. L. 105–277, div. C, title VIII, § 834, Oct. 21, 1998, 112 Stat. 2681–702.) Editorial Notes CODIFICATION Section was enacted as part of the Western Hemi- sphere Drug Elimination Act, and not as part of the Of- fice of National Drug Control Policy Reauthorization Act of 1998 which comprises this chapter. § 1714. Awards for demonstration programs by local partnerships to coerce abstinence in chronic hard-drug users under community supervision through the use of drug testing and sanctions (a) Awards required The Director shall make competitive awards to fund demonstration programs by eligible partnerships for the purpose of reducing the use of illicit drugs by chronic hard-drug users living in the community while under the supervision of the criminal justice system. (b) Use of award amounts Award amounts received under this section shall be used— (1) to support the efforts of the agencies, or- ganizations, and researchers included in the eligible partnership; (2) to develop and field a drug testing and graduated sanctions program for chronic hard- drug users living in the community under criminal justice supervision; and (3) to assist individuals described in sub- section (a) by strengthening rehabilitation ef- forts through such means as job training, drug treatment, or other services. (c) Eligible partnership defined In this section, the term ‘‘eligible partner- ship’’ means a working group whose application to the Director— (1) identifies the roles played, and certifies the involvement of, two or more agencies or organizations, which may include— (A) State, local, or tribal agencies (such as those carrying out police, probation, pros- ecution, courts, corrections, parole, or treat- ment functions); (B) Federal agencies (such as the Drug En- forcement Agency, the Bureau of Alcohol, Tobacco, Firearms, and Explosives, and United States Attorney offices); and